160 related articles for article (PubMed ID: 15291033)
61. Amyotrophic lateral sclerosis and gene therapy.
Miller TM; Smith RA; Cleveland DW
Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
[No Abstract] [Full Text] [Related]
62. Pseudotyped lentiviral vectors for tract-targeting and application for the functional control of selective neural circuits.
Kato S; Kobayashi K
J Neurosci Methods; 2020 Oct; 344():108854. PubMed ID: 32663549
[TBL] [Abstract][Full Text] [Related]
63. Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.
Abdellatif AA; Pelt JL; Benton RL; Howard RM; Tsoulfas P; Ping P; Xu XM; Whittemore SR
J Neurosci Res; 2006 Aug; 84(3):553-67. PubMed ID: 16786574
[TBL] [Abstract][Full Text] [Related]
64. Rabies virus envelope glycoprotein targets lentiviral vectors to the axonal retrograde pathway in motor neurons.
Hislop JN; Islam TA; Eleftheriadou I; Carpentier DC; Trabalza A; Parkinson M; Schiavo G; Mazarakis ND
J Biol Chem; 2014 Jun; 289(23):16148-63. PubMed ID: 24753246
[TBL] [Abstract][Full Text] [Related]
65. High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors.
Ahmed SG; Waddington SN; Boza-Morán MG; Yáñez-Muñoz RJ
J Control Release; 2018 Mar; 273():99-107. PubMed ID: 29289570
[TBL] [Abstract][Full Text] [Related]
66. Endothelin-mediated induction of heme oxygenase-1 in the spinal cord is attenuated in transgenic mice overexpressing superoxide dismutase.
Weinzierl M; Mautes AE; Whetstone W; Lin Y; Noble-Haeusslein LJ
Brain Res; 2004 Dec; 1030(1):125-32. PubMed ID: 15567344
[TBL] [Abstract][Full Text] [Related]
67. Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis.
McEachin ZT; Donsante A; Boulis N
Methods Mol Biol; 2016; 1382():399-408. PubMed ID: 26611602
[TBL] [Abstract][Full Text] [Related]
68. Amyotrophic lateral sclerosis (ALS) and extremely-low frequency (ELF) magnetic fields: a study in the SOD-1 transgenic mouse model.
Poulletier de Gannes F; Ruffié G; Taxile M; Ladevèze E; Hurtier A; Haro E; Duleu S; Charlet de Sauvage R; Billaudel B; Geffard M; Veyret B; Lagroye I
Amyotroph Lateral Scler; 2009; 10(5-6):370-3. PubMed ID: 19922126
[TBL] [Abstract][Full Text] [Related]
69. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
70. Lentivirus-mediated superoxide dismutase1 gene delivery protects against oxidative stress-induced liver injury in mice.
Venugopal SK; Wu J; Catana AM; Eisenbud L; He SQ; Duan YY; Follenzi A; Zern MA
Liver Int; 2007 Dec; 27(10):1311-22. PubMed ID: 18036097
[TBL] [Abstract][Full Text] [Related]
71. Myelosuppressive conditioning using busulfan enables bone marrow cell accumulation in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Lewis CA; Manning J; Barr C; Peake K; Humphries RK; Rossi F; Krieger C
PLoS One; 2013; 8(4):e60661. PubMed ID: 23593276
[TBL] [Abstract][Full Text] [Related]
72. Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery.
Boulis NM; Willmarth NE; Song DK; Feldman EL; Imperiale MJ
Neurosurgery; 2003 Feb; 52(2):381-7; discussion 387. PubMed ID: 12535368
[TBL] [Abstract][Full Text] [Related]
73. AAV6-mediated gene silencing fALS short.
Mandel RJ; Lowenstein PR; Byrne BJ
Mol Ther; 2011 Feb; 19(2):231-3. PubMed ID: 21289637
[No Abstract] [Full Text] [Related]
74. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases.
Azzouz M; Mazarakis N
Curr Gene Ther; 2004 Sep; 4(3):277-86. PubMed ID: 15384941
[TBL] [Abstract][Full Text] [Related]
75. Direct Injection of a Lentiviral Vector Highlights Multiple Motor Pathways in the Rat Spinal Cord.
Keefe KM; Junker IP; Sheikh IS; Campion TJ; Smith GM
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933070
[TBL] [Abstract][Full Text] [Related]
76. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.
Thomas AM; Palma JL; Shea LD
J Control Release; 2015 Apr; 204():1-10. PubMed ID: 25724274
[TBL] [Abstract][Full Text] [Related]
77. Effect of intra-cisternal application of kainic acid on the spinal cord and locomotor activity in rats.
Mitra NK; Goh TE; Bala Krishnan T; Nadarajah VD; Vasavaraj AK; Soga T
Int J Clin Exp Pathol; 2013; 6(8):1505-15. PubMed ID: 23923068
[TBL] [Abstract][Full Text] [Related]
78. Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells.
Garanina EE; Mukhamedshina YO; Salafutdinov II; Kiyasov AP; Lima LM; Reis HJ; Palotás A; Islamov RR; Rizvanov AA
Spinal Cord; 2016 Jun; 54(6):423-30. PubMed ID: 26439843
[TBL] [Abstract][Full Text] [Related]
79. [Gene therapy of ALS with RNA interference].
Yokota T
Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
[TBL] [Abstract][Full Text] [Related]
80. Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector.
Lockowandt M; Günther DM; Quintino L; Breger LS; Isaksson C; Lundberg C
J Neurosci Methods; 2020 Apr; 336():108542. PubMed ID: 32017975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
